Yew Bio Pharm Group (YEWB) 0.0590 $YEWB
Yew Bio-Pharm Group Reports 2016 First Quarter Financial Results
PR Newswire - Mon May 16, 3:00PM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCQB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle made with yew essence oil in China, today reported financial results for the three months ended March 31, 2016.
Yew Bio-Pharm Group Reports 2015 Fourth Quarter and Full Year Financial Results
PR Newswire - Wed Mar 30, 3:02PM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle made with yew essence oil in China, today reported financial results for the three- and twelve-months ended December 31, 2015.
Yew Bio-Pharm Group Reports 2015 Third Quarter Financial Results
PR Newswire - Mon Nov 16, 8:00AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today reported financial results for the three- and nine-months ended September 30, 2015.
Yew Bio-Pharm Group Signs the Tripartite Joint Planting Auricularia Auricula Contract and Acquires Financial Supporting from BOCOM
PR Newswire - Mon May 11, 7:00AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (YEWB), a major grower and seller of yew trees and yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today announced that Harbin Yew Science and Technology Development Co., Ltd., a wholly-owned subsidiary of the Company ("HDS" entered into the Tripartite Joint Planting Auricularia Auricula Contract (the "Agreement" with Harbin Wuchang Xinlin Forestry Co., Ltd. ("Wuchang" and 15 Farmer Households (the "Farmers" to joint develop a project involving the growing, harvesting, selling Auricularia Auricula products (Commonly known as the Wood Ear Mushroom). To ensure the successful execution of the project, Mr. Zhiguo Wang, the CEO and principal stockholder of the Company, collateralized his personal assets with Bank of Communications ("BOCOM" Harbin Rongtong Branch to secure a loan to fund the project. Upon extensive review on the Company and the project, BOCOM has approved a loan totaling RMB 10,000,000 (approx. $1,630,000) to HDS. The proceeds of the loan will be used by HDS to implement its obligations under the Agreement.
Yew Bio-Pharm Group Reports Improved Financial Results For 2014 Third Quarter
PR Newswire - Mon Nov 17, 8:30AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today reported financial results for the three- and nine-months ended September 30, 2014.
Yew Bio-Pharm Establishes New Subsidiary to Focus on Organic Foods and Functional Beverages
PR Newswire - Tue Nov 04, 8:30AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (OTCBB: YEWB), today announced the creation of a new subsidiary, Harbin Yew Food Co. LTD., to develop and cultivate black fungus. The company plans to operate three production lines to include black fungus polysaccharide, powder, tea and other packaged black fungus products. The move marks the Company's entrance into the organic food and functional beverage market.
Yew Bio-Pharm Applauds China State Forestry Administration's Creation of Subsidies to Encourage Chinese Medicinal Herb Crops
PR Newswire - Thu Oct 30, 8:30AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber, today applauded the creation of a subsidy program by the State Forestry Administration of China to promote the development and growth of Chinese medicinal herb crops.
Yew Bio-Pharm Signs Exclusive Distribution Agreement with Carpal Aid to Market Carpal Tunnel Syndrome Product in China
PR Newswire - Mon Oct 13, 7:05AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company" (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber in China, today announced a multi-year exclusive distribution agreement with Carpal Aid to distribute its non-invasive medical device "Carpal Aid" for carpal tunnel syndrome throughout China.
Yew Bio-Pharm Group Reports 2016 First Quarter Financial Results
PR Newswire - Mon May 16, 3:00PM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCQB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle made with yew essence oil in China, today reported financial results for the three months ended March 31, 2016. Yew Bio-Pharm Group Reports 2015 Fourth Quarter and Full Year Financial Results
PR Newswire - Wed Mar 30, 3:02PM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle made with yew essence oil in China, today reported financial results for the three- and twelve-months ended December 31, 2015. Yew Bio-Pharm Group Reports 2015 Third Quarter Financial Results
PR Newswire - Mon Nov 16, 8:00AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today reported financial results for the three- and nine-months ended September 30, 2015. Yew Bio-Pharm Group Signs the Tripartite Joint Planting Auricularia Auricula Contract and Acquires Financial Supporting from BOCOM
PR Newswire - Mon May 11, 7:00AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(YEWB), a major grower and seller of yew trees and yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today announced that Harbin Yew Science and Technology Development Co., Ltd., a wholly-owned subsidiary of the Company ("HDS" entered into the Tripartite Joint Planting Auricularia Auricula Contract (the "Agreement" with Harbin Wuchang Xinlin Forestry Co., Ltd. ("Wuchang" and 15 Farmer Households (the "Farmers" to joint develop a project involving the growing, harvesting, selling Auricularia Auricula products (Commonly known as the Wood Ear Mushroom). To ensure the successful execution of the project, Mr. Zhiguo Wang, the CEO and principal stockholder of the Company, collateralized his personal assets with Bank of Communications ("BOCOM" Harbin Rongtong Branch to secure a loan to fund the project. Upon extensive review on the Company and the project, BOCOM has approved a loan totaling RMB 10,000,000 (approx. $1,630,000) to HDS. The proceeds of the loan will be used by HDS to implement its obligations under the Agreement. Yew Bio-Pharm Group Reports Improved Financial Results For 2014 Third Quarter
PR Newswire - Mon Nov 17, 8:30AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today reported financial results for the three- and nine-months ended September 30, 2014. Yew Bio-Pharm Establishes New Subsidiary to Focus on Organic Foods and Functional Beverages
PR Newswire - Tue Nov 04, 8:30AM CST
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCBB: YEWB), today announced the creation of a new subsidiary, Harbin Yew Food Co. LTD., to develop and cultivate black fungus. The company plans to operate three production lines to include black fungus polysaccharide, powder, tea and other packaged black fungus products. The move marks the Company's entrance into the organic food and functional beverage market. Yew Bio-Pharm Applauds China State Forestry Administration's Creation of Subsidies to Encourage Chinese Medicinal Herb Crops
PR Newswire - Thu Oct 30, 8:30AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber, today applauded the creation of a subsidy program by the State Forestry Administration of China to promote the development and growth of Chinese medicinal herb crops. Yew Bio-Pharm Signs Exclusive Distribution Agreement with Carpal Aid to Market Carpal Tunnel Syndrome Product in China
PR Newswire - Mon Oct 13, 7:05AM CDT
Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company"
(OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber in China, today announced a multi-year exclusive distribution agreement with Carpal Aid to distribute its non-invasive medical device "Carpal Aid" for carpal tunnel syndrome throughout China. 
